{"url":"https://lda.senate.gov/api/v1/filings/fd318aec-17b6-4bd2-8ca2-dfd8087cc495/","filing_uuid":"fd318aec-17b6-4bd2-8ca2-dfd8087cc495","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2012,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/fd318aec-17b6-4bd2-8ca2-dfd8087cc495/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Carol A. McDaid, Principal","dt_posted":"2012-04-20T17:01:16.183000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"101 Constitution Avenue, NW","registrant_address_2":"Suite 675 East","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":55165,"url":"https://lda.senate.gov/api/v1/registrants/55165/","house_registrant_id":35118,"name":"CAPITOL DECISIONS, INC.","description":"Government Relations Consultant","address_1":"800 Maine Avenue, SW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"H. STEWART VAN SCOYOC","contact_telephone":"+1 202-638-0326","dt_updated":"2026-01-30T16:54:17.258236-05:00"},"client":{"id":159312,"url":"https://lda.senate.gov/api/v1/clients/159312/","client_id":1003934,"name":"ALKERMES","general_description":"Biotechnology company","client_government_entity":false,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-02-20"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues regarding access to Pharmacotherapies for addicition: \n      S. 1572/H.R.2596, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2012\n      S.1599,Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, FY2012\nAdd to #17 below:National Institute of Drug Abuse (NIDA)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42349,"prefix":"ms","prefix_display":"MS.","first_name":"CAROL","nickname":null,"middle_name":null,"last_name":"MCDAID","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67685,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":"MERBAUM","last_name":"STRAIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Public Law 110-343, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008\nMental health and addiction parity.\n\nAdd to #17 below:  National Institute of Drug Abuse (NIDA); and Center for Substance Abuse Treatment (CSAT). Public Law 110-374, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, Regulations implementation, Mental health and addiction parity.\n\nAccess and reimbursement issues regarding alcohol pharmacotherapies.\n\nS.1231, Second Chance Reauthorization Act of 2011, Demonstration project issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42349,"prefix":"ms","prefix_display":"MS.","first_name":"CAROL","nickname":null,"middle_name":null,"last_name":"MCDAID","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67685,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":"MERBAUM","last_name":"STRAIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Public Law 110-343, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008\nMental health and addiction parity.\n\nAdd to #17 below:  National Institute of Drug Abuse (NIDA); and Center for Substance Abuse Treatment (CSAT). Public Law 110-374, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, Regulations implementation, Mental health and addiction parity.\n\nAccess and reimbursement issues regarding alcohol and opioid pharmacotherapies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42349,"prefix":"ms","prefix_display":"MS.","first_name":"CAROL","nickname":null,"middle_name":null,"last_name":"MCDAID","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67685,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":"MERBAUM","last_name":"STRAIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[{"name":"ALKERMES PLC","contribution":"0.00","ownership_percentage":"100.00","address":"ConnaughtHouse,1BurlingtonRd","city":"Dublin 4","state":null,"state_display":null,"country":"IE","country_display":"Ireland","ppb_city":"Dublin 4","ppb_state":null,"ppb_state_display":null,"ppb_country":"IE","ppb_country_display":"Ireland"}],"affiliated_organizations":[]}